Journal article

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

Suzanne C Dixon, Christina M Nagle, Aaron P Thrift, Paul DP Pharoah, Celeste Leigh Pearce, Wei Zheng, Jodie N Painter, Georgia Chenevix-Trench, Peter A Fasching, Matthias W Beckmann, Diether Lambrechts, Ignace Vergote, Sandrina Lambrechts, Els Van Nieuwenhuysen, Mary Anne Rossing, Jennifer A Doherty, Kristine G Wicklund, Jenny Chang-Claude, Anja Rudolph, Kirsten B Moysich Show all

International Journal of Epidemiology | OXFORD UNIV PRESS | Published : 2016

Grants

Awarded by National Cancer Institute at the U.S. National Institutes of Health


Awarded by European Commission


Awarded by Cancer Research UK


Awarded by National Institutes of Health


Awarded by Cancer Post-GWAS Initiative


Awarded by U.S. Department of Defense


Awarded by Canadian Institutes of Health Research (CIHR)


Awarded by U.S. Army Medical Research and Materiel Command


Awarded by National Health and Medical Research Council of Australia


Awarded by Cancer Australia


Awarded by German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research


Awarded by Roswell Park Cancer Institute Alliance Foundation


Awarded by National Institutes of Health/National Center for Research Resources/General Clinical Research Center


Awarded by American Cancer Society Early Detection Professorship


Awarded by National Center for Advancing Translational Sciences (NCATS)


Awarded by Danish Cancer Society


Awarded by Imperial Experimental Cancer Research Centre


Awarded by U.S. Public Health Service


Awarded by Lon V. Smith Foundation


Awarded by California Cancer Research Program


Awarded by Polish Ministry of Science and Higher Education


Funding Acknowledgements

This work was supported by: the National Cancer Institute at the U.S. National Institutes of Health [K07-CA095666, K07-CA80668, K07-CA143047, K22-CA138563, N01-CN025403, N01-CN55424, N01-PC67001, N01-PC67010, P01-CA17054, P30-CA072720, P30-CA008748, P30-CA14089, P30-CA15083, P50-CA105009, P50-CA136393, P50-CA159981, R01-CA058860, R01 CA063678, R01 CA063682, R01-CA092044, R01-CA095023, R01-CA16056, R01-CA54419, R01-CA58598, R01-CA61107, R01-CA61132, R01-CA76016, R01-CA83918, R01-CA87538, R01-CA112523, R01-CA122443, R03-CA113148, R03-CA115195, U01-CA69417, U01-CA71966 and Intramural Research funds]; the European Commission's Seventh Framework Programme [agreement number 223175 HEALTH F2 2009-223175]; Cancer Research UK [C490/A16561, C536/A13086, C536/A6689, C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, and C8197/A16565]; a National Institutes of Health (CA128978), Cancer Post-GWAS Initiative [1U19-CA148537, 1U19-CA148065 and 1U19-CA148112 - the Genetic Associations and Mechanisms in Oncology (GAME-ON) initiative]; the U.S. Department of Defense [DAMD17-02-1-0669, W81XWH-07-0449, DAMD17-02-1-0666, W81XWH-10-1-0280 and W81XWH-10-1-0341]; the Canadian Institutes of Health Research (CIHR) [MOP-86727 and MSH-87734 to L.E.K.] and the CIHR Team in Familial Risks of Breast Cancer; the Komen Foundation for the Cure; the Breast Cancer Research Foundation; the Ovarian Cancer Research Fund (thanks to donations by the family and friends of Kathryn Sladek Smith); the U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729 and DAMD17-02-1-0669]; the National Health and Medical Research Council of Australia [199600, 400281, 209057, 251533, 396414, 504715, 1073898 and fellowships to G.C-T. and P.M.W.]; Cancer Australia [Multi-State Grant Application Numbers 191, 211 and 182]; Cancer Council Queensland; Cancer Council Victoria; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the ELAN Program of the University of Erlangen-Nuremberg; the Nationaal Kankerplan of Belgium; the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research [01GB 9401]; the German Cancer Research Center; the Roswell Park Cancer Institute Alliance Foundation [P30 CA016056]; the Rudolf-Bartling Foundation; the Helsinki University Central Hospital Research Fund; the National Institutes of Health/National Center for Research Resources/General Clinical Research Center [M01-RR000056]; an American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN to B.Y.K.]; the National Center for Advancing Translational Sciences (NCATS) [UL1TR000124 to B.Y.K.]; the Danish Cancer Society [94-222-52]; the Mermaid I project; the Mayo Foundation; the Minnesota Ovarian Cancer Alliance; the Fred C. and Katherine B. Andersen Foundation; the Cancer Institute of New Jersey; Helse Vest; the Norwegian Cancer Society; the Research Council of Norway; Radboud University Medical Centre; the Oregon Health and Science University (OHSU) Foundation; Pomeranian Medical University; the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, University College London Hospital and the Royal Marsden Hospital; the Imperial Experimental Cancer Research Centre [C1312/A15589]; the U.S. Public Health Service [PSA-042205]; the Lon V.Smith Foundation [LVS-39420]; the Eve Appeal; the Oak Foundation; the California Cancer Research Program [00-01389V-20170 and 2II0200]; the Polish Ministry of Science and Higher Education [4 PO5C 028 14 and 2 PO5A 068 27]; and the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.